Boundless Bio 10% owner Kevin Tang reports acquisition of $51,619.20 in common shares

BOLD•2026-10-26

Kevin Tang, a 10% owner of Boundless Bio, purchased 21,640 common shares through indirect ownership, increasing reported beneficial ownership to 3,011,749 shares.

1. Share purchases

Tang purchased 5,800 shares at $2.40 each and 15,840 shares at $2.38 each. The purchases totaled $51,619.20.

Sources

Boundless Bio 10% owner Kevin Tang reports acquisition of $51,619.20 in common shares

Sec

Boundless Bio 10% owner Kevin Tang reports acquisition of $51,619.20 in common shares

1. Share purchases

Related News

P&G files for four-part notes offering of up to $4 billion

Bullish, Equiniti token coalition adds QRT, Vertalo and zerohash

Metalúrgica Gerdau proposes dividend of R$ 0.16 per share

Sources

Boundless Bio 10% owner Kevin Tang reports acquisition of $51,619.20 in common shares

Aptar Pharma acquires Pulmotree

Entravision grants director Gary Ferrera 15,023 restricted stock units